PND6 COMPARISON OF COSTS FOR INTERFERON BETA 1-A AND NATALIZUMAB IN PATIENTS WITH MULTIPLE SCLEROSIS
May 1, 2009, 00:00 AM
10.1016/S1098-3015(10)74013-4
https://www.valueinhealthjournal.com/article/S1098-3015(10)74013-4/fulltext
Section Title :
Section Order :
503
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74013-4&doi=10.1016/S1098-3015(10)74013-4